Muscle, Health and Costs: A Glance at their Relationship
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the association between muscle parameters (mass, strength, physical performance) and activities of daily living (ADL), quality of life (QoL), and health care costs. DESIGN: Cross-sectional Maastricht Sarcopenia Study (MaSS). SETTING: Community-dwelling, assisted-living, residential living facility. PARTICIPANTS: 227 adults aged 65 and older. MEASUREMENTS: Muscle mass, hand grip strength and physical performance were assessed by bio-electrical impedance, JAMAR dynamometer and the Short Physical Performance Battery, respectively. Health outcomes were measured by the Groningen Activity Restriction Scale (disability in ADL) and the EQ-5D-5L (QoL). Health care costs were calculated based on health care use in the past three months. RESULTS: Muscle strength and physical performance showed a strong correlation with ADL, QoL, and health care costs (P<.01); for muscle mass no significant correlations were observed. Regression analyses showed that higher gait speed (OR 0.06, 95%CI 0.01-0.55) was associated with a lower probability of ADL disability. Furthermore, slower chair stand (OR 1.23, 95%CI 1.08-1.42), and more comorbidities (OR 1.58, 95%CI 1.23-2.02) were explanatory factors for higher ADL disability. Explanatory factors for QoL and costs were: more disability in ADL (OR 1.26, 95%CI 1.12-1.41 for QoL; B = 0.09, P<.01 for costs) and more comorbidities (OR 1.44, 95%CI 1.14-1.82 for QoL; B = 0.35, P<.01 for costs). CONCLUSION: Lower gait speed and chair stand were potential drivers of disability in ADL. Disability in ADL and comorbidities were associated with QoL and health care costs in community-dwelling older adults. Improving physical performance may be a valuable target for future intervention and research to impact health burden and costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736 · cited 2×
“ADL function (GARS score) 19 (18-25) 18 (18-20) 27 (22-34) 32 (19-46) <.”
MethodSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 5×
“Moderate sarcopenia 41 (18) 14 (9) 12 (30) 15 (52)”
MethodInfluentialGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792 · cited 2×
“ADL function (GARS score) 19 (18-25) 18 (18-20) 27 (22-34) 32 (19-46) <.”
MethodBioelectrical impedance analysis?part I: review of principles and methods
KYLE, U. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.06.004 · Cited by 3,200 · cited 1×
“Muscle mass was assessed by bio-electrical impedance (BIA Akern Srl, Florence, Italy 101, 50 kHz) according to the ESPEN guidelines (15).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482 · cited 2×
“Muscle mass was calculated using the Janssen et al.(16) equation: skeletal muscle mass (kg) = [(height2/BIA analysis resistance×0.”
MethodInfluentialSkeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Cesari, M., Kritchevsky, S. B., Newman, A. B., Simonsick, E. M., Harris, T. B., Penninx, B. W., Brach, J. S., Tylavsky, F. A., Satterfield, S., Bauer, D. C., et al. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02126.x · Cited by 702 · cited 2×
“ADL function (GARS score) 19 (18-25) 18 (18-20) 27 (22-34) 32 (19-46) <.”
BackgroundBauer, J. M., Verlaan, S., Bautmans, I., Brandt, K., Donini, L. M., Maggio, M., McMurdo, M. E. T., Mets, T., Seal, C., Wijers, S. L., et al. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.05.021 · Cited by 670
Self-citationMijnarends, D. M., Meijers, J. M. M., Halfens, R. J. G., ter Borg, S., Luiking, Y. C., Verlaan, S., Schoberer, D., Cruz Jentoft, A. J., van Loon, L. J. C., & Schols, J. M. G. A. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.10.009 · Cited by 475 · cited 1×
“Muscle measures The measures used for muscle mass, strength and performance were evaluated as valid and feasible for the measurement of sarcopenia in a community setting (14).”
MethodSelf-citationCawthon, P. M., Fox, K. M., Gandra, S. R., Delmonico, M. J., Chiou, C., Anthony, M. S., Sewall, A., Goodpaster, B., Satterfield, S., Cummings, S. R., et al. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02366.x · Cited by 414 · cited 4×
“Furthermore, muscle mass, muscle strength, and physical performance have their own distinct effect on health and economic outcomes (2-5, 9).”
BackgroundInfluentialKempen, G. I. J. M., Miedema, I., Ormel, J., & Molenaar, W. (1996) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00057-3 · Cited by 393 · cited 6×
“The scores for ADL function and QoL found in the current study lie in between scores found in previous studies using the GARS and the EQ-5D (30-32).”
MethodInfluentialVisser, M., & Schaap, L. A. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.006 · Cited by 320
Hand grip strength and incident ADL disability in elderly Mexican Americans over a seven-year period
Snih, S. A., Markides, K. S., Ottenbacher, K. J., & Raji, M. A. (2004) · Aging Clinical and Experimental Research · doi:10.1007/bf03327406 · Cited by 285 · cited 3×
“Previous studies on the association between muscle parameters (1-4) or sarcopenia (5-8) and QoL, disability in activities of daily living (ADL) and health care utilization show inconsistent results.”
BackgroundDefining Sarcopenia in Terms of Incident Adverse Outcomes
Woo, J., Leung, J., & Morley, J. E. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.013 · Cited by 261 · cited 2×
“Previous studies on the association between muscle parameters (1-4) or sarcopenia (5-8) and QoL, disability in activities of daily living (ADL) and health care utilization show inconsistent results.”
BackgroundQuality of life and physical components linked to sarcopenia: The SarcoPhAge study
Beaudart, C., Reginster, J. Y., Petermans, J., Gillain, S., Quabron, A., Locquet, M., Slomian, J., Buckinx, F., & Bruyère, O. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.05.003 · Cited by 248 · cited 6×
“The scores for ADL function and QoL found in the current study lie in between scores found in previous studies using the GARS and the EQ-5D (30-32).”
ResultInfluentialFinancial impact of sarcopenia on hospitalization costs
Sousa, A. S., Guerra, R. S., Fonseca, I., Pichel, F., Ferreira, S., & Amaral, T. F. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.73 · Cited by 211 · cited 4×
“Previous studies on the association between muscle parameters (1-4) or sarcopenia (5-8) and QoL, disability in activities of daily living (ADL) and health care utilization show inconsistent results.”
BackgroundResultInfluentialHirani, V., Blyth, F., Naganathan, V., Le Couteur, D. G., Seibel, M. J., Waite, L. M., Handelsman, D. J., & Cumming, R. G. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.02.006 · Cited by 191 · cited 2×
“Previous studies on the association between muscle parameters (1-4) or sarcopenia (5-8) and QoL, disability in activities of daily living (ADL) and health care utilization show inconsistent results.”
BackgroundThe Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study
Bianchi, L., Ferrucci, L., Cherubini, A., Maggio, M., Bandinelli, S., Savino, E., Brombo, G., Zuliani, G., Guralnik, J. M., Landi, F., et al. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv129 · Cited by 181 · cited 2×
“(10) did find an association between sarcopenia defined by the EWGSOP and disability, hospitalization and mortality.”
BackgroundMijnarends, D. M., Schols, J. M. G. A., Meijers, J. M. M., Tan, F. E. S., Verlaan, S., Luiking, Y. C., Morley, J. E., & Halfens, R. J. G. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.011 · Cited by 175 · cited 2×
“A detailed description of the methodology and in- and exclusion criteria of the Maastricht Sarcopenia Study (MaSS) has been previously published (11, 12).”
MethodSelf-citationAssociation between Sarcopenia, Bone Density, and Health-Related Quality of Life in Korean Men
Go, S. W., Cha, Y. H., Lee, J. A., & Park, H. S. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.4.281 · Cited by 127 · cited 4×
“ADL function (GARS score) 19 (18-25) 18 (18-20) 27 (22-34) 32 (19-46) <.”
ResultInfluentialde Vries, N. M., Staal, J. B., van der Wees, P. J., Adang, E. M. M., Akkermans, R., Olde Rikkert, M. G. M., & Nijhuis‐van der Sanden, M. W. G. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12091 · Cited by 117
Yoshimura, Y., Uchida, K., Jeong, S., & Yamaga, M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0570-4 · Cited by 82 · cited 3×
“Furthermore, nutritional intervention has been shown to improve muscle mass, physical performance and ADL function (28-29), and may therefore be used in the strategy to combat both malnutrition and sarcopenia related negative health outcomes and costs.”
BackgroundSarcopenia predicts costs among patients undergoing major abdominal operations
Gani, F., Buettner, S., Margonis, G. A., Sasaki, K., Wagner, D., Kim, Y., Hundt, J., Kamel, I. R., & Pawlik, T. M. (2016) · Surgery · doi:10.1016/j.surg.2016.05.002 · Cited by 77
Cesari, M., Rolland, Y., Abellan Van Kan, G., Bandinelli, S., Vellas, B., Ferrucci, L., & Kritchevsky, S. (2015) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu181 · Cited by 66 · cited 3×
“Furthermore, muscle mass, muscle strength, and physical performance have their own distinct effect on health and economic outcomes (2-5, 9).”
BackgroundGobbens, R. J. J., van Assen, M. A. L. M., & Schalk, R. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.06.008 · Cited by 54 · cited 4×
“ADL function (GARS score) 19 (18-25) 18 (18-20) 27 (22-34) 32 (19-46) <.”
ResultInfluentialGroessl, E. J., Kaplan, R. M., Castro, C. M., Church, T. S., Espeland, M. A., Gill, T. M., Glynn, N. W., King, A. C., Kritchevsky, S. B., Manini, T. M., et al. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw001 · Cited by 49 · cited 2×
“It has been shown that physical activity interventions can improve QoL and are cost-effective (25, 26).”
BackgroundMijnarends, D. M., Schols, J. M. G. A., Halfens, R. J. G., Meijers, J. M. M., Luiking, Y. C., Verlaan, S., & Evers, S. (2016) · European Geriatric Medicine · doi:10.1016/j.eurger.2015.12.011 · Cited by 43 · cited 6×
“Severe sarcopenia 12 (5) 5 (3) 5 (12) 2 (7)”
BackgroundMethodSelf-citationWOO, T., YU, S., & VISVANATHAN, R. (2016) · Journal of Frailty & Aging · doi:10.14283/jfa.2016.93 · Cited by 41 · cited 4×
“Furthermore, muscle mass, muscle strength, and physical performance have their own distinct effect on health and economic outcomes (2-5, 9).”
BackgroundInfluentialLo, Y. C., Wahlqvist, M. L., Huang, Y.-C., Chuang, S., Wang, C.-F., & Lee, M. (2017) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-017-0487-x · Cited by 39 · cited 3×
“(27) showed that a lower skeletal muscle mass index was associated with higher health care costs over 8 years, but high dietary diversity and more physical activity attenuated these effects.”
BackgroundOne-year postoperative resource utilization in sarcopenic patients
Kirk, P. S., Friedman, J. F., Cron, D. C., Terjimanian, M. N., Wang, S. C., Campbell, D. A., Englesbe, M. J., & Werner, N. L. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.04.074 · Cited by 33 · cited 2×
“ADL function (GARS score) 19 (18-25) 18 (18-20) 27 (22-34) 32 (19-46) <.”
ResultSarcopenia and Health Care Utilization in Older Women
Cawthon, P. M., Lui, L.-Y., McCulloch, C. E., Cauley, J. A., Paudel, M. L., Taylor, B., Schousboe, J. T., & Ensrud, K. E. (2017) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw118 · Cited by 24 · cited 5×
“Severe sarcopenia 12 (5) 5 (3) 5 (12) 2 (7)”
BackgroundInfluential
Cited by
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Self-citationSieber, C. C. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01170-1 · Cited by 355
Hsu, K.-J., Liao, C.-D., Tsai, M.-W., & Chen, C.-N. (2019) · Nutrients · doi:10.3390/nu11092163 · Cited by 258
Billot, M., Calvani, R., Urtamo, A., Sánchez-Sánchez, J. L., Ciccolari-Micaldi, C., Chang, M., Roller-Wirnsberger, R., Wirnsberger, G., Sinclair, A., Vaquero-Pinto, M. N., et al. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s253535 · Cited by 242
“without intervention, sarcopenia and frailty often lead to disability, falls, and a decline in quality of life.(11) There is also an increased risk of hospitalization and death.”
BackgroundSelf-citationChen, N., He, X., Feng, Y., Ainsworth, B. E., & Liu, Y. (2021) · European Review of Aging and Physical Activity · doi:10.1186/s11556-021-00277-7 · Cited by 178
“This brings a heavy economic burden to societies and families if sarcopenia is untreated [10].”
Background
Metadata
- Authors
- Mijnarends, D. M., Luiking, Y. C., Halfens, R. J. G., Evers, S. M. A. A., Lenaerts, E. L. A., Verlaan, S., Wallace, M., Schols, J. M. G. A., & Meijers, J. M. M.
- Venue
- The Journal of nutrition, health and aging
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 22
- Issue
- 7
- Pages
- 766-773
- ISSN
- 1279-7707 (ISSN-L)
- OpenAlex
- W2807979624
- Cited by
- 173
- References
- 31
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.